StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
NEOG

Neogen Corporation

NEOG Nasdaq In Vitro & In Vivo Diagnostic Substances EDGAR ↗
$11.90
+0.37 +3.21%

Key statistics

from XBRL data in SEC filings
Market cap
$2.59B
Revenue (TTM)
$870M
Net income (TTM)
-$7.90M
EPS (TTM)
$-0.04
P/E ratio
Dividend yield
Free cash flow
$31.9M
Cash
$186M
Total assets
$3.35B
Gross margin
46.9%
52-week range
$4.63 – $12.85

Recent SEC filings

40 most recent
Annual, quarterly & current reports
10-K Fiscal year ended 2026-05-31 Jul 30, 2026 8-K Results of operations (earnings release) Jul 30, 2026 8-K Regulation FD disclosure Apr 20, 2026 10-Q Quarter ended 2026-02-28 Apr 9, 2026 8-K Results of operations (earnings release) Apr 9, 2026 8-K Director or officer change Mar 30, 2026 10-Q Quarter ended 2025-11-30 Jan 8, 2026 8-K Results of operations (earnings release) Jan 8, 2026 8-K Director or officer change; Other events Oct 30, 2025 8-K/A Director or officer change Oct 28, 2025 8-K/A Shareholder vote results Oct 27, 2025 8-K Shareholder vote results Oct 27, 2025 10-Q Quarter ended 2025-08-31 Oct 9, 2025 8-K Results of operations (earnings release) Oct 9, 2025 8-K Director or officer change; Other events Sep 15, 2025 8-K Director or officer change Aug 21, 2025 8-K Director or officer change; Other events Aug 14, 2025 10-K Fiscal year ended 2025-05-31 Jul 30, 2025 8-K Results of operations (earnings release) Jul 29, 2025 8-K Director or officer change; Other events Jul 24, 2025 8-K Regulation FD disclosure Jun 4, 2025 8-K Regulation FD disclosure May 14, 2025 8-K Director or officer change; Other events May 13, 2025 8-K Regulation FD disclosure Apr 22, 2025 10-Q Quarter ended 2025-02-28 Apr 9, 2025 8-K Director or officer change Apr 9, 2025 8-K Results of operations (earnings release) Apr 9, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Regulation FD disclosure Apr 7, 2025 10-Q Quarter ended 2024-11-30 Jan 15, 2025 8-K Results of operations (earnings release) Jan 10, 2025 8-K Director or officer change Jan 7, 2025 8-K/A Director or officer change Dec 17, 2024 8-K Regulation FD disclosure Dec 4, 2024 8-K Shareholder vote results Oct 28, 2024 10-Q Quarter ended 2024-08-31 Oct 10, 2024 8-K Director or officer change Oct 10, 2024 8-K Results of operations (earnings release) Oct 10, 2024 8-K Director or officer change; Other events Oct 1, 2024 8-K Regulation FD disclosure Sep 5, 2024 10-K Fiscal year ended 2024-05-31 Jul 30, 2024